![](/img/cover-not-exists.png)
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. OzaVolume:
30
Language:
english
Pages:
6
DOI:
10.1007/s10637-011-9650-4
Date:
June, 2012
File:
PDF, 116 KB
english, 2012